Cargando…
Death by TNF: a road to inflammation
Tumour necrosis factor (TNF) is a central cytokine in inflammatory reactions, and biologics that neutralize TNF are among the most successful drugs for the treatment of chronic inflammatory and autoimmune pathologies. In recent years, it became clear that TNF drives inflammatory responses not only d...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665039/ https://www.ncbi.nlm.nih.gov/pubmed/36380021 http://dx.doi.org/10.1038/s41577-022-00792-3 |
_version_ | 1784831210769350656 |
---|---|
author | van Loo, Geert Bertrand, Mathieu J. M. |
author_facet | van Loo, Geert Bertrand, Mathieu J. M. |
author_sort | van Loo, Geert |
collection | PubMed |
description | Tumour necrosis factor (TNF) is a central cytokine in inflammatory reactions, and biologics that neutralize TNF are among the most successful drugs for the treatment of chronic inflammatory and autoimmune pathologies. In recent years, it became clear that TNF drives inflammatory responses not only directly by inducing inflammatory gene expression but also indirectly by inducing cell death, instigating inflammatory immune reactions and disease development. Hence, inhibitors of cell death are being considered as a new therapy for TNF-dependent inflammatory diseases. |
format | Online Article Text |
id | pubmed-9665039 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-96650392022-11-16 Death by TNF: a road to inflammation van Loo, Geert Bertrand, Mathieu J. M. Nat Rev Immunol Review Article Tumour necrosis factor (TNF) is a central cytokine in inflammatory reactions, and biologics that neutralize TNF are among the most successful drugs for the treatment of chronic inflammatory and autoimmune pathologies. In recent years, it became clear that TNF drives inflammatory responses not only directly by inducing inflammatory gene expression but also indirectly by inducing cell death, instigating inflammatory immune reactions and disease development. Hence, inhibitors of cell death are being considered as a new therapy for TNF-dependent inflammatory diseases. Nature Publishing Group UK 2022-11-15 2023 /pmc/articles/PMC9665039/ /pubmed/36380021 http://dx.doi.org/10.1038/s41577-022-00792-3 Text en © Springer Nature Limited 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Article van Loo, Geert Bertrand, Mathieu J. M. Death by TNF: a road to inflammation |
title | Death by TNF: a road to inflammation |
title_full | Death by TNF: a road to inflammation |
title_fullStr | Death by TNF: a road to inflammation |
title_full_unstemmed | Death by TNF: a road to inflammation |
title_short | Death by TNF: a road to inflammation |
title_sort | death by tnf: a road to inflammation |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665039/ https://www.ncbi.nlm.nih.gov/pubmed/36380021 http://dx.doi.org/10.1038/s41577-022-00792-3 |
work_keys_str_mv | AT vanloogeert deathbytnfaroadtoinflammation AT bertrandmathieujm deathbytnfaroadtoinflammation |